Improving the Selection of Patients With Glioblastoma Multiforme for Treatment With Epidermal Growth Factor Receptor Inhibitor Therapies

Plain-language summary

This study aimed to better select glioblastoma multiforme patients for EGFR inhibitor therapies by performing gene and protein expression analyses. It included patients previously enrolled on the N0177 and N0074 trials who had suitable archived tissue samples. Run by the Alliance for Clinical Trials in Oncology, it was a study without an assigned phase and has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Completed

Sponsor

Alliance for Clinical Trials in Oncology

Intervention

gene expression analysis, microarray analysis, protein expression analysis, diagnostic laboratory biomarker analysis, immunohistochemistry staining method

Start date

11/1/2006

Estimated completion

1/1/2018

Countries

United States

Related genes

Locations

• Scottsdale, United States
• Jacksonville, United States
• Sioux City, United States
• Sioux City, United States
• Sioux City, United States
• Rochester, United States
• Bismarck, United States
• Bismarck, United States
• Bismarck, United States
• Rapid City, United States

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

All patients entered onto N0177 and N0074 who have appropriate archived clinical specimens.